Tumor Associated Antigen Specific T Cells (TAA-T) With PD1 Inhibitor for Lymphoma
Clinical trial NCT03843294 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03843294
- Sponsor
- Catherine Bollard
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-24
- Primary completion
- 2023-05-02
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.